An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study
Ignacio Romero, María Jesús Rubio, Manuel Hidalgo Medina, Xavier Matías‐Guiu, Marı́a Santacana, Juan-Antonio Schoenenberger, Eva Guerra, Alfonso Cortés, Lucas Minig, Pluvio Coronado, Juan Cueva, L. Galvis Gomez, Andrea Malfettone, Miguel Sampayo, Antonio Llombart‐Cussac, Andrés Poveda
Topics & Concepts
OlaparibMedicinePARP inhibitorCyclin D1OncologyInternal medicineCancer researchBiomarkerCell cyclePoly ADP ribose polymeraseCancerBiologyEnzymePolymeraseBiochemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Breast Cancer Therapies